Country: Taiwan
Bahasa: Cina
Sumber: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
APREPITANT
旌宇藥業股份有限公司 臺南市南區喜樹路67號1樓 (80044233)
A04AD12
膠囊劑
APREPITANT (9200095800) MG
ALU-OPA/ALU/PVC 鋁箔盒裝
製 劑
須由醫師處方使用
PHARMATHEN INTERNATIONAL S.A. INDUSTRIAL PARK, 5TH BLOCK, 69300, SAPES, RODOPI, GREECE GR
aprepitant
與其他止吐藥劑併用,可以防止由高致吐性及中致吐性癌症化療藥物在初次或重覆使用時所引起的急性或延遲性噁心與嘔吐。
有效日期: 2027/12/06; 英文品名: Aprevitae 80mg hard capsules
2022-12-06
治敏吐ጼ $SUHYLWDH+DUGCAPSULES ҙᜈ༂үᚌ৻ЩڄҬ $SUHYLWDH+DUG&DSVXOHV80 హք ፙဗᜈᒹԏಛ ှ $SUHYLWDH+DUG&DSVXOHV125 హք ፙဗᜈᒹԏಛ ှ އᕥЁᝂ $prepitant ࢚Σᆗ substance P neurokinin 1 (NK 1 ) Ϩڱᡧࢆ״ᏢȎ ಬԣ ؚᘅ ωݒጼ֮ 80 హքܠ 125 హք aprepitant ˤ ؚᘅጼ֮θӠ፷צᏢ 0LFURFU\VWDOOLQH&HOOXORVHSXULILHGZDWHU+\SURPHOORVH6XFURVH3ROR[DPHU 。先 ♲㭤䘬ㆸ↮䁢 6RGLXP /DXU\O 6XOIDWH ( *HODWLQ 3XULILHGZDWHU %ODFN 3ULQWLQJ ,QN 。 PJ 膠囊含 7LWDQLXPGLR[LGH( ; PJ 膠囊含 ,URQR[LGH5HG( ᖧסᜈᏺ պҬᐪᚇ Aprepitant ژԮᑉੵީպҬዋԜȑڙᄑΫᝂ substance P neurokinin 1(NK 1 ) ީ௯ڱᡧȌ ژԮᒿᐏܜᇎେࡣᒛӵβީࢆ״ᏢȎဎүऄᄑᑬᒿᔸᡥݼ (counter-screening assay) ᡡ Һᇎڙьሟીȍᚇႆޚ (transporter) ȍϏഇႈ (ion channel) шЏաЇᕥПଞީ◩Р ہქӯ (Chemotherapy Induced Nausea and Vomiting Ȍ CINV) ᕥݼϨዉީڱᡧѝࢌԅЛ ἇ (dopamine) ᇎՠెી (serotonin) ީڱᡧ๓вႀϨθȌ aprepitant ᄑ NK 1 ީᒿᐏܜЗ େ 3,000 অшκȎ ᖧסࠓऌيᡡҺȌ NK 1 - ڱᡧࢆ״Ꮲѩш᙮үϥወպҬȌڣүಪवࢽܜᝂЇᕥᜈޚ ( ڇ ԍȒ cisplatin) ܤПଞީქӯȎᖧסࠓऌيᇎΫᡧҝϏ݃৬ᘨኃ௷ᆊ (Positron Emission Tomography, PET) ީݘᡡҺȌ aprepitant ѩшघഐ໖έဨകȌٸնᐍဨകީ NK 1 ڱ ᡧȎᖧסࠓऌيᡡҺȌ aprepitant ᄑϥወًಥީպҬਬࡨߧȌѩшڣ cisplatin Пଞ ީࡲܜිᇎ܇ᓀිީქӯȌٸѩቲெژЯӯպҬީ 5-HT 3 - ڱᡧࢆ״Ꮲ ondansetron ᇎҴ ᝂۈ dexamethasone ๓ᄑ cisplatin ܤПଞީქӯީڣպҬȎ ᜈ ୧ᏺ (PHARMACOKINETICS) ֦ԧ Aprepitant ީҋֹᄑωݒҫᡧѩҬ౯ (mean absolute oral bioavailability) ύढࣙ 60 65% ȌՎ aprepitant ީҋֹീେՠϥᐲࡣ (C max ) ύढјӿݒᜈ 4 ϓਬ (T max ) Ȏ Aprepitant ጼᇎዉྯԨᓫΣଞݒҬਬȌᄑ aprepitant ωݒҫᡧѩҬ౯ȌӿᖧסκتԮ ᡡީኑ៴Ȏ ӿᖧסᏢໞጜ൦ϻȌ Baca dokumen lengkap